ZG36 is used as a human Caseinolytic protease P (ClpP) agonist to non-selectively degrade respiratory chain complexes and reduce mitochondrial DNA, leading to mitochondrial dysfunction and death of leukemia cells; it also inhibits the development of acute myeloid leukemia in xenograft mouse models.